Wilson Sonsini Goodrich Rosati

WebsiteDirections Contact us

$96
OFF

Wilson Sonsini Advises NEA In Monte Rosa Therapeutics’ $96 …

6 days from now

On September 24, 2020, Monte Rosa Therapeutics, a biotechnology company developing precision medicines to degrade disease-causing proteins, announced the closing of a $96 …

wsgr.com

$96
OFF

Monte Rosa Therapeutics’ $96 Million Series B Financing

6 days from now

Sep 28, 2020 · Wilson Sonsini Goodrich & Rosati advised New Enterprise Associates on the deal. Goodwin Procter LLP advised Monte Rosa Therapeutics on the deal. Walder Wyss acted as …

globallegalchronicle.com

$96
OFF

The Life Sciences Report - Winter 2021 | Wilson Sonsini Goodrich ...

6 days from now

Jan 29, 2021 · Monte Rosa Therapeutics Raises $96 Million in Series B Financing On September 24, 2020, Monte Rosa Therapeutics, a biotechnology company developing precision …

jdsupra.com

$96
OFF

NEA Backs $96M Round For Cancer Therapy Startup - PitchBook

6 days from now

Sep 25, 2020 · Monte Rosa Therapeutics has raised a $96 million Series B led by Aisling Capital, with participation from Versant Ventures and NEA. Based near Boston, the biotech startup is a …

pitchbook.com

$52
OFF

Insights | Wilson Sonsini

6 days from now

Wilson Sonsini Advises Radionetics Oncology on IP Matters Related to $52.5 Million Series A On January 3, 2024, San Diego-based Radionetics Oncology, a clinical stage radiopharmaceutical …

wsgr.com

$175
OFF

Insights | Wilson Sonsini

6 days from now

Oct 11, 2023 · Wilson Sonsini Advises Novo Holdings A/S and Vida Ventures on Avalyn Pharma's $175 Million Series C On September 27, 2023, Avalyn Pharma Inc., a clinical-stage …

wsgr.com

$65
OFF

Life Sciences | Wilson Sonsini

6 days from now

Wilson Sonsini Advises GC Therapeutics on $65 Million Series A. Client Highlights 09/19/24. Wilson Sonsini Advises JP Morgan Life Sciences Private Capital on Pathalys Pharma’s $105 …

wsgr.com

$18
OFF

Biotech | Wilson Sonsini

6 days from now

Wilson Sonsini Advises Digestiva on $18.4 Million Series A Financing Client Highlights 07/16/24 Wilson Sonsini Advises Iambic Therapeutics on $50 Million Series B Extension, Bringing Total …

wsgr.com

$50
OFF

Insights | Wilson Sonsini

6 days from now

Wilson Sonsini Advises Aeovian Pharmaceuticals on Patent Matters Related to $50 Million Series A On March 28, 2024, Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company …

wsgr.com

$670000
OFF

Dozens Arrested Had Mob Ties In Gambling Ring Bust, Authorities Say

6 days from now

Dec 5, 2016 · Authorities seized $670,000 from a safety deposit box held by Cicalese and his wife, Rose, 72, who was also charged. The investigation began in April 2003 as a probe into …

northjersey.com

$100
OFF

Wilson Sonsini Advises Amber Therapeutics On IP Matters Related …

6 days from now

Wilson Sonsini Advises Amber Therapeutics on IP Matters Related to $100M Series A Financing, One of Europe’s Largest for a MedTech Company. 06/10/24 ... The round, one of the largest …

wsgr.com

$12
OFF

Wilson Sonsini Advises Tempo Therapeutics On $12 Million Series A

6 days from now

On March 19, 2024, Tempo Therapeutics, a leading innovator in tissue engineering and regenerative medicine, announced the completion of a $12 million Series A equity financing …

wsgr.com